Last updated on February 2018

Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Gastric Cancer


Brief description of study

Objectives

To evaluate the safety and effectiveness of cell therapy using Precision Cell Immunotherapy to treat Advanced Gastric Cancer.

Eligibility

Individuals greater than or equal to 18 years of age and less than or equal to 65 years of age who have been diagnosed with Advanced Gastric Cancer.

Detailed Study Description

A total of 40 patients may be enrolled over a period of 1-2 years.

Clinical Study Identifier: NCT02862561

Contact Investigators or Research Sites near you

Start Over

Naiyan Han

Shanghai International Medical Center
Shanghai, China
  Connect »